HOME >> BIOLOGY >> NEWS
Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies

NEW YORK, NY, August 26, 2004 Guidant Corporation of Indianapolis, Ind., Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart. This five-year, phased investment will build on recent basic research conducted at the universities. The goal of the program is to develop better treatment options for people with heart disease. Terms of the investment are not being disclosed.

Research at the universities suggests the possibility of developing a biological pacemaker, one that can vary the heart's beats to fit the body's needs, as is required during variations in exercise or emotion.

"The opportunity to translate this important technology from basic research into human therapy fits in with our mission at Columbia University Medical Center," said Gerald D. Fischbach, M.D., executive vice president and dean of the faculty of medicine at CUMC. "We look forward to collaborating with Guidant and Stony Brook and harnessing the potential of this new treatment."

"This extraordinary venture with Columbia and Guidant vastly expands the possibilities to enhance research into gene therapy," said Gail Habicht, Ph.D., Stony Brook vice president for research.

Research will be conducted in four laboratories at the universities: those of Michael R. Rosen, M.D., Gustavus A Pfeiffer Professor of Pharmacology and professor of pediatrics at Columbia; Richard B. Robinson, Ph.D., professor of pharmacology at Columbia; Ira S. Cohen, M.D., Ph.D., Leading Professor of Physiology & Biophysics at Stony Brook; and Peter R. Brink, Ph.D., professor and chairman of Physiology and Biophysics at Stony Brook. The research grew out of collaborations between Columbia's Center for Molecular Therapeutics, headed by Dr. Rosen, and Stony Brook's Institute of Molecular Cardiology, headed by Dr. Cohen.

"Our par
'"/>

Contact: Annie Bayne
as862@columbia.edu
212-305-3900
Columbia University Medical Center
26-Aug-2004


Page: 1 2

Related biology news :

1. Worlds largest scientific society holds regional meeting in Columbia, Mo.
2. Similarities Found In Human, Chimp Brains; Columbia, Mount Sinai, NIH Scientists Find Region That Controls Language Identical In Both Species
3. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
4. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
5. Wisconsin scientists develop quick botox test
6. Bronfenbrenner book sums up human development
7. Researchers develop fast track way to discover how cells are regulated
8. DuPont developing new protective suits for military, first responders
9. OutFoxed! New research may redefine late-stage cardiac development
10. Computer scientists at UH developing nurturing computers
11. Disease diagnosis, drug development focus of UH profs biochip research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... TORONTO (PRWEB) , ... June 22, 2020 , ... The ... time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of ... several years. , This now necessitates the question “How do you choose which approach ...
(Date:6/23/2020)... ... 2020 , ... In its June 22 online post, business and technology news ... M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb ... that starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... Your Lab with Software for Data Decisions,” for pharmaceutical and biotech executives, ... integrate and automate cutting-edge scientific instruments and laboratory equipment from dozens of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... eSource has ... inefficiencies. This webinar will cover the history of eSource, the reasons it did not ... EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver ... “It’s the only technology of its kind on the market and we were pleased ... the protective capacity of traditional cultured ingredients, creating a natural way to extend the ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining ... research team led by Dr MA has been using the zebrafish model to ...
Breaking Biology Technology:
Cached News: